C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
12/2004
12/14/2004	US6830765 Extract of green tea containing from 20% to 50% by mass of catechols expressed as epigallocatechol gallate
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/09/2004	WO2004106338A1 Novel crystalline forms of valacyclovir hydrochloride
12/09/2004	WO2004106337A1 Xanthine derivatives as a2b adenosine receptor antagonists
12/09/2004	WO2004063151A3 Novel tyrosine kinase inhibitors
12/09/2004	US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group
12/09/2004	US20040248910 Synthesis of acyclic nucleoside derivatives
12/09/2004	US20040248908 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
12/09/2004	US20040248907 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors
12/09/2004	CA2524778A1 Xanthine derivatives as a2b adenosine receptor antagonists
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178660C Antiviral combinations of lamivudine and adefovir
12/07/2004	US6828450 Triptycene analogs
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/02/2004	US20040242599 Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
12/02/2004	US20040242598 Phosphodiesterase 4 inhibitors
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480966A1 Compounds and methods of treating cell proliferative diseases
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP0882727B1 Novel purine derivatives
12/01/2004	CN1551880A Crystalline forms of valacyclovir hydrochloride
12/01/2004	CN1550553A Process for the preparation of (1S,4R) or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene and its derivatives or its salts
12/01/2004	CN1550500A Process for the preparation of (1S,4R) or (1R,4S)-4-(2-amino-6-chloro-9-H-purine-9-group)-2-cyclopentenyl-1-methanol or its salts
12/01/2004	CN1550490A Process for the preparation of aminoalcohol and (1S,4Rú®or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene or its salts
11/2004
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	CA2315733C Type 2 helper t cell-selective immune response inhibitors
11/30/2004	CA2087922C 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparation process and antidepressant, nootropic and psychostimulant composition thereof
11/25/2004	WO2004101554A1 New indole derivatives as factor xa inhibitors
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	US20040235869 For therapy of subject infected with a retrovirus
11/25/2004	US20040235868 Purine derivatives having, in particular, anti-proliferative properties and their biological uses
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	CA2526066A1 New indole derivatives as factor xa inhibitors
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479677A1 New indole derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries
11/24/2004	CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/23/2004	US6822089 From corresponding ribonucleosides by forming 3-tert-butylphenoxythiocarbonyl derivatives and effecting radical deoxygenation; solid phase synthesis
11/23/2004	US6821979 Synergistic enhancement of cognitive ability
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821429 Method and device for capturing fine particles by trapping in a solid mixture of carbon dioxide snow type
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/18/2004	WO2004099208A1 Process for the preparation of famciclovir
11/18/2004	WO2004099207A1 Microcrystal
11/18/2004	WO2004035132A3 Compositions and methods for inducing osteogenesis
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229887 Novel imidazopyrimidinyl and imidazopyri dinyl derivatives
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229836 Compounds having selective hydrolytic potentials
11/18/2004	CA2525191A1 Prodrugs cleavable by cd26
11/18/2004	CA2522573A1 Process for the preparation of famciclovir
11/17/2004	EP1165560B1 2-hydroxy methylcyclopro pylidenemethyl purines as antiviral agents
11/17/2004	CN1547582A Synthesis of branched acyclic nucleosides
11/17/2004	CN1176096C Technology for producing AR with IR as initiation material by liquid ammonia process
11/16/2004	CA2145181C Process for preparing 1-2,-substituted-5-formylimidazoles
11/11/2004	WO2004096811A1 Pde9 inhibitors for treating type 2 diabetes, metabokic syndrome, and cardiovascular disease
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/10/2004	EP1104415B1 Method of manufacture of 1,3-oxathiolane nucleosides
11/10/2004	EP0958821B1 Fat emulsion containing xanthine derivative
11/10/2004	CN1544434A 6-benzylaminopurine production process
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6814986 Composition for treating obesity and esthetic treatment process
11/04/2004	WO2004094595A2 MODIFIED iRNA AGENTS
11/04/2004	WO2004094449A1 Macrolide-conjugates with anti-inflammatory activity
11/04/2004	WO2004094447A1 Thionucleoside s-nitrosyl derivative
11/04/2004	WO2004094426A1 (purin-6-yl) amino acid and production method thereof
11/04/2004	US20040220186 phosphodiesterase inhibitors
11/04/2004	CA2522637A1 Modified irna agents
11/04/2004	CA2507893A1 (purin-6-yl) amino acid and production method thereof
11/03/2004	EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004	EP1472254A2 Purine and isosteric antibacterial compounds
11/03/2004	CN1173976C Use of antineoplastic active compound nitrene-phin
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/02/2004	US6812232 Heterocycle substituted purine derivatives as potent antiproliferative agents
11/02/2004	US6811998 Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
10/2004
10/28/2004	WO2004058791A3 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/28/2004	US20040214834 Pyrazolo-pyridines for the treatment of herpes infections
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/27/2004	EP1470114A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
10/27/2004	EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists

1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 120